A German contract research company said yesterday that it will open a laboratory and manufacturing facility in Baltimore County to provide services to biomedical companies.
The announcement, made by the state's secretary of economic and employment development, Mark L. Wasserman, at a meeting of the Greater Baltimore Committee last night, was a boost for the state's efforts to attract new life-sciences businesses to the region.
LAB Pharmaceutical Services Inc., the Maryland subsidiary of LAB GmbH & Co. of Germany, contracts with biotechnology and drug companies, particularly small companies, that need technical advice getting new drugs through the federal regulatory process and to market. The company also will help sell and license drugs internationally and provide clinical supplies.
The company was drawn to the Baltimore area because of its proximity to the federal Food and Drug Administration and the National Institutes of Health in Bethesda, potential clients in Baltimore and Pennsylvania, and three large universities, said LAB Pharmaceutical's president, Norbert L. Wiech.
Baltimore also has many biotechnology companies and is working to make the area a center for medicine, biotechnology and scientific research.
Founded in March, LAB Pharmaceutical has seven employees in Owings Mills, Mr. Wiech said. But the company hopes to move soon to a facility near Golden Ring Mall. By 1995, it plans to have 50 employees, he said.
Mr. Wiech, a biochemist, has been a consultant to LAB GmbH & Co. and a 20-year employee of Marion Merrill Dow, a large pharmaceutical company.